NEW YORK (TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.
MDRNA (MRNA) opened higher by 84 cents, or 88.6%, to $1.79 after the company reported potent anti-tumor activity against both liver and bladder cancers via both systemic and local delivery with its proprietary UsiRNAs delivered by its novel DiLA2 platform. The 50-day average daily volume for MDRNA is 292,000, according to the Nasdaq.
Hythiam (HYTM) jumped by 3 cents, or 6.6%, to 54 cents at the start of trading after a published paper sponsored by the company noted predictive models that can be utilized as the basis for Hythiam to develop new and innovative approaches for substance dependence solutions that result in improved member care and reduced costs for payors. The 50-day average daily volume for Hythiam is 1.02 million.
LeCroy (LCRY) rallied by 47 cents, or 13%, to $4.08 in early trading after the company said it expects fiscal second quarter revenue of approximately $31 million, which is above the $29.9 million average of two analyst estiamtes. The 50-day average daily volume for LeCroy is 25,000.Affymetrix (AFFX) slumped by 74 cents, or 11.5%, to $5.70 in early trading after Barclays downgraded the stock to underweight from equal weight. The firm also lowered its price target on Affymetrix to $3 from $6. The 50-day average daily volume for Affymetrix is 1.24 million.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV